Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

v3.20.1
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities    
Loss for the period $ (5,302,904) $ (5,465,486)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization of intangible assets 8,403 13,548
Change in fair value of derivative liability (852)
Warrants issued for services 133,297 36,534
Shares issued for services 12,286 10,269
Performance stock unit expense 183,205
Stock option expense 307,028 355,388
Changes in operating assets and liabilities    
Prepaid expenses and deposits 165,383 794,859
Interest, taxes and other receivables 15,848 30,433
Accounts payable and accrued liabilities (658,946) (425,383)
Related party payables (29,024) (47,189)
Net cash used in operating activities (5,348,629) (4,514,674)
Cash flows from financing activities    
Net proceeds from the issuance of shares and warrants 6,582,966
Net proceeds from the exercise of warrants 26,550 726,179
Series A preferred stock dividend (6,267) (6,267)
Deferred financing costs (25,000)
Net cash provided by financing activities 6,603,249 694,912
Increase (decrease) in cash and cash equivalents 1,254,620 (3,819,762)
Cash and cash equivalents - beginning of period 3,718,758 5,971,995
Cash and cash equivalents - end of period $ 4,973,378 $ 2,152,233